A Study of Tooth Erosion in People With Esophagogastric Cancer
NCT05612048 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174
Last updated 2026-03-23
Summary
The researchers are doing this study to find out more about what may lead to the loss of tooth enamel (the thin outer covering of the tooth) and how often it happens in people with esophagogastric cancer, colorectal cancer, pancreatic cancer, breast cancer, head and neck cancer, or non-small cell lung cancer, or a healthy volunteer.
Conditions
- Esophagogastric Cancer
Interventions
- OTHER
-
Survey
This is a 15-item questionnaire. The questionnaire asks subjects to quantify, during a specified duration of time, the number of times they have consumed or completed a task (ex. alcohol intake, cigarette use, and teeth brushing frequency). Additionally, the questionnaire further asks subjects to quantify their GERD symptoms and risk factors prior to diagnosis. All study procedures will be completed in one visit as part of a standard-of-care clinic visit.
- OTHER
-
Intra-oral camera
Intraoral pictures of molars and incisors in 13 key regions
- OTHER
-
Optional Salvia sample
Cohort 1 only. Participant is responsible for collecting and bringing the salvia sample to clinic.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Steven Maron, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-03
- Primary Completion
- 2027-11-30
- Completion
- 2027-11-30
Countries
- United States
Study Locations
More Related Trials
-
Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer
NCT06499298 ·Status: COMPLETED
-
The Microbiome of Oesophageal Squamous Cell Carcinoma
NCT04425122 ·Status: UNKNOWN
-
Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study
NCT06189898 ·Status: RECRUITING
-
Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
NCT05552651 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical Surgery
NCT06418945 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
NCT06190847 ·Status: RECRUITING
-
A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.
NCT07203898 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT01561014 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
NCT05183958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
NCT05659251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma
NCT06690476 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
NCT06510660 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)
NCT06143748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy
NCT06063941 ·Status: COMPLETED ·Phase: NA
-
A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.
NCT07251062 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
NCT06173986 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
NCT01164566 ·Status: TERMINATED ·Phase: NA
-
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
NCT00629863 ·Status: COMPLETED ·Phase: NA
-
Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma
NCT01034683 ·Status: UNKNOWN ·Phase: PHASE3
-
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT
NCT06598917 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
NCT05213312 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
NCT00208936 ·Status: TERMINATED ·Phase: PHASE2
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer
NCT02606396 ·Status: COMPLETED ·Phase: NA
-
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
NCT05621707 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2